Blog

May 28, 2024, 08:56

Angelo Pirozzi: CAR-T cells targeting claudin18.2 in pretreated advanced PDAC by Changsong Qi et al.

Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix), made the following post on X:

”CAR-T cells targeting claudin-18.2 in pretreated advanced PDAC.

2 phase I/Ib trials with 24 patients.
79% ≥2 previous systemic lines.
ORR 16.7%.
DCR 70.8%.
mPFS 3.3 months.
mOS 10.0 months.
mDoR 9.5 months.”

Read further.
Source: Angelo Pirozzi/X

Angelo Pirozzi cancer CAR-T cells Chang Liu Changsong Qi Claudin-18.2 Daijing Yuan Dan Liu Jiajia Yuan Jian Li Jifang Gong Jun Zhang Jun Zhou Lin Shen Miao Zhang Ning Li OncoDaily Oncology Panpan Zhang PDAC Raffaele Baffa Xiaohui Peng Xiaotian Zhang Xicheng Wang Yumeng Wang Zhen Liu

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage